Literature DB >> 23391253

Maximal estimated cardiorespiratory fitness, cardiometabolic risk factors, and metabolic syndrome in the aerobics center longitudinal study.

Conrad P Earnest1, Enrique G Artero, Xuemei Sui, Duck-chul Lee, Timothy S Church, Steven N Blair.   

Abstract

OBJECTIVE: To examine the relationship between estimated maximal cardiorespiratory fitness (CRF) and metabolic syndrome (MetSyn). PATIENTS AND METHODS: We performed a cross-sectional analysis of 38,659 Aerobics Center Longitudinal Study participants seen between January 1, 1979, and December 31, 2006, to examine CRF levels defined as low (lower 20%), moderate (middle 40%), and high (upper 40%) of age- and sex-specific distributions vs National Cholesterol Education Program-derived MetSyn expressed as a summed z-score continuous variable. We used a general linear model for continuous variables, the χ(2) test for distribution of categorical variables, and multiple linear regression for single and cumulative MetSyn scores adjusted for body mass index, smoking status, alcohol intake, and family history of cardiovascular disease.
RESULTS: We observed significant inverse trends for MetSyn vs CRF in both sexes (P for trend <.001). The CRF associations vs individual components were as follows: waist circumference-men: β=-.14, r(2)=0.78; women: β=-.04, r(2)=0.71; triglycerides-men: β=-.29, r(2)=0.18; women: β=-.17, r(2)=0.18; high-density lipoprotein cholesterol-men: β=.25, r(2)=0.17; women: β=.08, r(2)=0.19; fasting glucose-men: β=-.09, r(2)=0.09; women: β=.09, r(2)=0.01; systolic blood pressure-men: β=-.09, r(2)=0.09; women: β=-.01, r(2)=0.21; and diastolic blood pressure-men: β=-.07, r(2)=0.12; women: β=-.05, r(2)=0.14. All associations except for systolic blood pressure (both sexes) and glucose (women) are significant (P<.001).
CONCLUSION: Cardiorespiratory fitness demonstrated a strong inverse relationship with MetSyn in both sexes, with the strongest single associative component being waist circumference.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391253      PMCID: PMC3622904          DOI: 10.1016/j.mayocp.2012.11.006

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  31 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield
Journal:  Arch Intern Med       Date:  2003-02-24

Review 3.  Exercise alone is an effective strategy for reducing obesity and related comorbidities.

Authors:  R Ross; J A Freeman; I Janssen
Journal:  Exerc Sport Sci Rev       Date:  2000-10       Impact factor: 6.230

4.  Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness?

Authors:  Paul W Franks; Ulf Ekelund; Søren Brage; Man-Yu Wong; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

5.  Effects of exercise and weight loss on cardiac risk factors associated with syndrome X.

Authors:  Lana L Watkins; Andrew Sherwood; Mark Feinglos; Alan Hinderliter; Michael Babyak; Elizabeth Gullette; Robert Waugh; James A Blumenthal
Journal:  Arch Intern Med       Date:  2003-09-08

Review 6.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  Interval training in men at risk for insulin resistance.

Authors:  C P Earnest; M Lupo; J Thibodaux; C Hollier; B Butitta; E Lejeune; N M Johannsen; M J Gibala; T S Church
Journal:  Int J Sports Med       Date:  2012-11-23       Impact factor: 3.118

8.  Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Jukka T Salonen; Leo K Niskanen; Rainer Rauramaa; Timo A Lakka
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

9.  Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study.

Authors:  Peter T Katzmarzyk; Arthur S Leon; Jack H Wilmore; James S Skinner; D C Rao; Tuomo Rankinen; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2003-10       Impact factor: 5.411

10.  Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome.

Authors:  Timo A Lakka; David E Laaksonen; Hanna-Maaria Lakka; Niko Männikkö; Leo K Niskanen; Rainer Rauramaa; Jukka T Salonen
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

View more
  33 in total

1.  Cut points of muscle strength associated with metabolic syndrome in men.

Authors:  Martin Sénéchal; Jonathan M McGavock; Timothy S Church; Duck-Chul Lee; Conrad P Earnest; Xuemei Sui; Steven N Blair
Journal:  Med Sci Sports Exerc       Date:  2014-08       Impact factor: 5.411

Review 2.  Impediments to clinical application of exercise interventions in the treatment of cardiometabolic disease.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

3. 

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

4.  Aerobic and strength training in concomitant metabolic syndrome and type 2 diabetes.

Authors:  Conrad P Earnest; Neil M Johannsen; Damon L Swift; Fiona B Gillison; Catherine R Mikus; Alejandro Lucia; Kimberly Kramer; Carl J Lavie; Timothy S Church
Journal:  Med Sci Sports Exerc       Date:  2014-07       Impact factor: 5.411

Review 5.  The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.

Authors:  George S Metsios; R H Moe; M van der Esch; J J C S Veldhuijzen van Zanten; S A M Fenton; Y Koutedakis; P Vitalis; N Kennedy; N Brodin; C Bostrom; T W Swinnen; K Tzika; K Niedermann; E Nikiphorou; G E Fragoulis; T P V M Vlieland; C H M Van den Ende; George D Kitas
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 6.  Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

Authors:  Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Renea Taylor; Gail P Risbridger; Mark Frydenberg; Michelle Hill; Suzanne K Chambers; Phillip Stricker; Tom Shannon; Dickon Hayne; Eva Zopf; Robert U Newton
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

7.  A cross-sectional study of cardiorespiratory fitness and gallbladder disease.

Authors:  Changqing Li; Catherine Mikus; Ali Ahmed; Gang Hu; Kaiyu Xiong; Yimin Zhang; Xuemei Sui
Journal:  Ann Epidemiol       Date:  2016-11-21       Impact factor: 3.797

8.  [Effects of BeHaS Program on Health Behavior, Physiologic Index and Self-Esteem of the Elderly Living Alone with Metabolic Syndrome Based on Community Based Participatory Research].

Authors:  Jong Im Kim; Sun Ae Kim; Keumok Park; Jiyoung Kim; Lina Lee; Si Wan Choi; Bon Jeong Ku
Journal:  J Korean Acad Nurs       Date:  2020-08       Impact factor: 0.984

9.  Dose effect of cardiorespiratory exercise on metabolic syndrome in postmenopausal women.

Authors:  Conrad P Earnest; Neil M Johannsen; Damon L Swift; Carl J Lavie; Steven N Blair; Timothy S Church
Journal:  Am J Cardiol       Date:  2013-04-08       Impact factor: 2.778

10.  Enhanced weight and fat loss from long-term intermittent fasting in obesity-prone, low-fitness rats.

Authors:  Mark E Smyers; Lauren G Koch; Steven L Britton; Jacob G Wagner; Colleen M Novak
Journal:  Physiol Behav       Date:  2020-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.